 | Up a level |
Journal Article
Camidge, Ross, Cappuzzo, Federico, Go, Jowell, Isaacson, Jeffrey, Litten, Jason, Park, Keunchil, Spigel, David R., Spira, Alexander, Vergnenegre, Alain, Wolf, Juergen, Yang, James Chih-Hsin and Mok, Tony (2015). TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC. J. Thorac. Oncol., 10 (9). S. S427 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Gautschi, Oliver, Milia-Baron, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David, Owen, Dwight, Camidge, D. Ross, Narayanan, Vighesh, Doebele, Robert, Besse, Benjamin 
ORCID: 0000-0001-5090-8189, Remon, Jordi, Janne, Pasi, Awad, Mark, Peled, Nir, Byoung, Chul-Cho, Karp, Daniel, Van den Heuve, Michael, Wakelee, Heather, Nea, Joel, Mok, Tony, Yang, James Chih-Hsin, Ou, Sai-Hong, Pa, Georg, Froesch, Patrizia, Zalcman, Gerard, Gandara, David R., Riess, Jonathan, Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Fruh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay ORCID: 0000-0003-2087-4963, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha ORCID: 0000-0003-1304-9340, Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian ORCID: 0000-0001-7204-5652, Mazieres, Julien and Drilon, Alexander
(2017).
Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung Cancers.
J. Thorac. Oncol., 12 (1).
S. S435 - 2.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Kim, Dong-Wan, Tan, Daniel Shao-Weng, Aix, Santiago Ponce, Sequist, Lecia V., Smit, Egbert F., Hida, Toyoaki, Yang, James Chih-Hsin, Felip, Enriqueta, Seto, Takashi, Grohe, Christian, Wolf, Juergen, Ko, Jinnie, Diallo, Mariama, Pultar, Philippe, Giovannini, Monica and Kim, Sang-We (2018). Preliminary Phase II results of a multicenter, open-label study of nazartinib (EGF816) in adult patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC). J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Solomon, Benjamin J., Loong, Herbert H. F., Summers, Yvonne J., Thomas, Zachary M., French, Pearl Plernjit, Lin, Boris K., Sashegyi, Andreas, Wolf, Juergen, Yang, James Chih-Hsin and Drilon, Alexander E. (2020). Correlation between overall response rate and progression-free survival/overall survival in comparative trials involving targeted therapies in molecularly enriched populations. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Tan, Daniel Shao-Weng, Leighl, Natasha B., Yang, James Chih-Hsin, Riely, Gregory J., Sequist, Lecia, V, Toyozawa, Ryo, Wolf, Juergen, Felip, Enriqueta, Kim, Sang-We, Aix, Santiago Ponce, Smit, Egbert F., Hida, Toyoaki, Grohe, Christian, Ghebremariam, Samson, O'Sullivan-Djentuh, Leslie, Belli, Riccardo, Giovannini, Monica and Kim, Dong-Wan (2020). Nazartinib (EGF816) in patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC): Updated phase II results. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Tan, Daniel Shao-Weng, Yang, James Chih-Hsin, Leighl, Natasha B., Riely, Gregory J., Sequist, Lecia V., Felip, Enriqueta, Seto, Takashi, Wolf, Juergen, Moody, Susan Elizabeth, Adams, Kenneth, Schmitz, Shu-Fang Hsu, Tan, Eugene Y. and Kim, Dong-Wan (2016). Updated results of a phase 1 study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Thress, Kenneth, Leeson, James, Geradts, Joseph, Schuler, Martin, Ahn, Myung-Ju, Wolf, Juergen, Gold, Kathryn A., Yang, James Chih-Hsin, Blackhall, Fiona, Su, Wu-Chou, Jacobs, Vivien, Smith, Neil R., Angell, Helen, Brown, Kathryn, Vishwanathan, Karthick, Barrett, J. Carl, Cantarini, Mireille and Jaenne, Pasi A. (2015). Design, Execution, and Preliminary Biomarker Results from Paired Tumor Biopsy Cohorts of the AZD9291 AURA Trial. J. Thorac. Oncol., 10 (9). S. S320 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Thress, Kenneth S., Jacobs, Vivien, Angell, Helen K., Yang, James Chih-Hsin ORCID: 0000-0002-5586-5138, Sequist, Lecia V., Blackhall, Fiona ORCID: 0000-0001-8716-3395, Su, Wu-Chou ORCID: 0000-0003-2953-4105, Schuler, Martin, Wolf, Juegen, Gold, Kathryn A., Cantarini, Mireille, Barrett, J. Carl and Janne, Pasi A.
(2017).
Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial.
J. Thorac. Oncol., 12 (10).
S. 1588 - 1595.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380